Markets:

Overview

News

Currencies

International

Treasuries

Foghorn Therapeutics Inc. - Common Stock (NQ:FHTX)

6.380 +1.220 (+23.64%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Foghorn Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week ↗

February 16, 2023

Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.

Via The Motley Fool

Foghorn Therapeutics Highlights Recent Clinical and Research Progress and Provides Strategic Objectives for 2023

January 09, 2023

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics Announces New Preclinical Data for FHD-286 in AML to Be Presented at the American Society of Hematology Annual Meeting

December 05, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics to Participate at the Evercore ISI HealthCONx Conference

November 22, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

4 Analysts Have This to Say About Foghorn Therapeutics ↗

August 10, 2022

Analysts have provided the following ratings for Foghorn Therapeutics (NASDAQ:FHTX) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting

November 14, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics to Present New Preclinical Data for BRG1/BRM Inhibitor FHD-286 in Combination with Anti-PD-1 Antibody at Society for Immunotherapy of Cancer 37th Annual Meeting

November 09, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update

November 08, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics Appoints Dr. Thomas J. Lynch, Jr. to Its Board of Directors

October 27, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics Announces New Data Demonstrating BRD9 Degradation in Patient Tumor Biopsies and Discloses New Selective CBP Program

October 26, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Foghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation Summit

October 20, 2022

From Foghorn Therapeutics, Inc.

Via GlobeNewswire

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022 ↗

August 24, 2022

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher ↗

August 23, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday.

Via Benzinga

Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday ↗

August 23, 2022

GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.

Via Benzinga

Nasdaq Turns Lower; Crude Oil Rises Sharply ↗

August 23, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday.

Via Benzinga

US Stocks Mixed; Dow Falls 50 Points ↗

August 23, 2022

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday.

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5% ↗

May 23, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday.

Via Benzinga

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge ↗

May 23, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday.

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

Via Benzinga

30 Stocks Moving In Monday's Mid-Day Session ↗

May 23, 2022

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Via Benzinga

66 Biggest Movers From Friday ↗

May 23, 2022

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.